Abstract

A neural glycotope, human natural killer-1 carbohydrate, is involved in synaptic plasticity. The key biosynthetic enzyme is a glucuronyltransferase, GlcAT-P, a type II membrane protein comprising an N-terminal cytoplasmic tail, transmembrane domain, stem region, and C-terminal catalytic domain. Previously, we reported that GlcAT-P has two isoforms differing in only the presence or absence of the N-terminal 13 amino acids (P-N13) in the cytoplasmic tail, but the functional distinction of these two isoforms has not been reported. Herein, we show that when expressed in Neuro2A cells, short form GlcAT-P (sGlcAT-P) exhibited significantly higher glucuronylation activity than the longer form (lGlcAT-P), despite their comparable specific activities in vitro. In addition, sGlcAT-P was strictly localized in Golgi apparatus, whereas lGlcAT-P was mainly localized in Golgi but partly in the endoplasmic reticulum. We demonstrated that the small GTPase, Sar1, recognized a dibasic motif in the cytoplasmic tail near P-N13 that was important for exiting the endoplasmic reticulum, and Sar1 interacted with sGlcAT-P more strongly than lGlcAT-P. Finally, the attachment of P-N13 to another glycosyltransferase, polysialyltransferase-I (ST8Sia-IV), had similar effects, such as reduced activity and entrapment within endoplasmic reticulum. These results suggest that P-N13 can control glycosyltransferase transport through Sar1 binding interference.

Highlights

  • A number of reports have revealed that glycosylation plays diverse roles in many biological events, such as development and disease progression [1]

  • Longer mRNAs containing the insertion were translated to the short form proteins and vice versa, and the long and short enzymes differed in only the presence or absence of the N-terminal 13 amino acids (P-N13) in the cytoplasmic tail (Fig. 2A, lGlcAT-P and sGlcATP)

  • We demonstrated that the two isoforms of the human natural killer-1 (HNK-1)-sythesizing enzyme, GlcAT-P, differing in only the N-terminal cytoplasmic tail length, showed significantly distinct behavior, such as in localization, secretion, and HNK1-producing activity in cells

Read more

Summary

Introduction

A number of reports have revealed that glycosylation plays diverse roles in many biological events, such as development and disease progression [1]. We show that when expressed in Neuro2A cells, short form GlcAT-P (sGlcAT-P) exhibited significantly higher glucuronylation activity than the longer form (lGlcAT-P), despite their comparable specific activities in vitro.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call